Search MCK
MCKESSON CORP
NYSE · CIK 927653
Last close902.28
Daily change+3.46 (0.38%)
10 Years gain+458.07%
Dividends TTM3.4 (+15.25%)
Dividend yield0.38%
Fundamental Analysis
MCK · STANDARD
SIC 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Fiscal year end 0331
Fundamental
69.8Momentum
50.2Acceleration
70.1Confidence
91.0Annual Revenue19
Quarterly Revenue83
Annual CFO19
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.3 / 25
Quality13.4 / 25
Capital Efficiency20.0 / 20
Balance Sheet5.6 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 0.0392 percentage points.
ROIC expansionROIC improved by 287.0508 percentage points.
Share count reductionDiluted share count declined 5.8452%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM33.52%OK
Revenue CAGR 3Y13.39%OK
Gross Margin3.44%OK
Operating Margin1.3%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC503.67%OK
Incremental Operating Margin 3Y2.25%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-5.85%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | $403.43B | $14.55B | $6.21B | $6.16B | $5.72B | 3.61% | 1.54% | 1.42% | n/a | 124.1M |
| 2026 FY Mar 31, 2025 | $359.05B | $13.32B | $4.42B | $6.09B | $5.55B | 3.71% | 1.23% | 1.55% | n/a | 128.1M |
| 2026 FY Mar 31, 2024 | $308.95B | $12.83B | $3.91B | $4.31B | $3.88B | 4.15% | 1.27% | 1.26% | n/a | 134.1M |
| 2025 FY Mar 31, 2023 | $276.71B | $12.36B | $4.38B | $5.16B | $4.77B | 4.47% | 1.58% | 1.72% | n/a | 142.2M |
| 2024 FY Mar 31, 2022 | $263.97B | $13.13B | $2.04B | $4.43B | $4.05B | 4.97% | 0.77% | 1.53% | 295.61% | 154.1M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $412.52B | sum latest 4 fiscal quarters Revenue | OK | 0000927653-26-000234, 0000927653-25-000140 |
| Revenue Growth TTM | 33.52% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000927653-26-000234, 0000927653-25-000140 |
| Revenue CAGR 3Y | 13.39% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000927653-26-000069 |
| Revenue CAGR 5Y | 11.11% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000927653-26-000069 |
| Gross Profit CAGR 3Y | 5.59% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000927653-26-000069 |
| Operating Income Growth | 37.66% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000927653-26-000234, 0000927653-25-000140 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 3.44% | Gross Profit / Revenue | OK | 0000927653-26-000234, 0000927653-25-000140 |
| Operating Margin | 1.3% | Operating Income / Revenue | OK | 0000927653-26-000234, 0000927653-25-000140 |
| ROIC | 503.67% | NOPAT / Average Invested Capital | OK | 0000927653-26-000234, 0000927653-25-000140 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000927653-26-000234 |
| Current Ratio | 0.89x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.53x | (Cash + Short-term Investments) / Total Debt | OK | 0000927653-26-000234 |
| Revenue per Diluted Share | $3,460.70 | Revenue / Diluted Shares | OK | 0000927653-26-000234, 0000927653-25-000140 |